LAURA AMIDON: Open Payments
NPI 1508967837 · MOUNT PULASKI, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 26 payments from 12 companies in 2025. Trend: 2023 $77 · 2024 $321 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $246 |
| Gilead Sciences, Inc. | 2 | $51 |
| Celltrion USA Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Octapharma USA, Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: RINVOQ, SKYRIZI, VEGZELMA, FIBRYGA, ZENPEP, EOHILIA, IBSRELA, REZDIFFRA.
Industry payments across IL — which companies pay providers there.
